Douglas W. Pagan - Net Worth and Insider Trading

Douglas W. Pagan Net Worth

The estimated net worth of Douglas W. Pagan is at least $298,947 dollars as of 2024-11-13. Douglas W. Pagan is the CFO of Paratek Pharmaceuticals Inc and owns about 134,057 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $298,947. Details can be seen in Douglas W. Pagan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas W. Pagan has not made any transactions after 2019-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Douglas W. Pagan

To

Douglas W. Pagan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas W. Pagan owns 3 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , Alaunos Therapeutics Inc (TCRT) , and Paratek Pharmaceuticals Inc (PRTK) .

Click here to see the complete history of Douglas W. Pagan’s form 4 insider trades.

Insider Ownership Summary of Douglas W. Pagan

Ticker Comapny Transaction Date Type of Owner
DRNA Dicerna Pharmaceuticals Inc 2020-06-01 Chief Financial Officer
TCRT Alaunos Therapeutics Inc 2018-09-18 director
PRTK Paratek Pharmaceuticals Inc 2019-02-05 Chief Financial Officer

Douglas W. Pagan Latest Holdings Summary

Douglas W. Pagan currently owns a total of 1 stock. Douglas W. Pagan owns 134,057 shares of Paratek Pharmaceuticals Inc (PRTK) as of February 5, 2019, with a value of $298,947.

Latest Holdings of Douglas W. Pagan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRTK Paratek Pharmaceuticals Inc 2019-02-05 134,057 2.23 298,947

Holding Weightings of Douglas W. Pagan


Douglas W. Pagan Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas W. Pagan has made a total of 0 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 2,495 shares on February 5, 2019, which brought Douglas W. Pagan around $16,891.

Insider Trading History of Douglas W. Pagan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas W. Pagan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Douglas W. Pagan Ownership Network

Ownership Network List of Douglas W. Pagan

No Data

Ownership Network Relation of Douglas W. Pagan

Insider Network Chart

Douglas W. Pagan Owned Company Details

What does Dicerna Pharmaceuticals Inc do?

Who are the key executives at Dicerna Pharmaceuticals Inc?

Douglas W. Pagan is the Chief Financial Officer of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .

Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dicerna Pharmaceuticals Inc Insider Transactions

No Available Data

Douglas W. Pagan Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas W. Pagan. You might contact Douglas W. Pagan via mailing address: 75 Kneeland Street, Boston Ma 02111.